Using over two calendar years of data across more than 230 covered entity sites, our 340B team analyzed aggregated data to understand which drugs, therapeutic classes, and medical specialties account for the largest savings realized through referral prescriptions within the contract pharmacy domain. This download documents the top-level findings.